comparemela.com

Latest Breaking News On - Score2 trial - Page 1 : comparemela.com

Bevacizumab First-line Treatment More Cost-Effective in RVO vs Aflibercept

Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.